Sera of patients with systemic lupus erythematosus react with plasmodial antigens and can inhibit the in vitro growth of Plasmodium falciparum

Autoimmunity

Volumn 42, Issue 6, 2009, Pages 545-552

  Zanini, Graziela Maria ^a   de Moura Carvalho, Leonardo José ^a   Brahimi, Karima ^b   de Souza Passos, Luiz Fernando ^c   Guimarães, Swami José ^d   da Silva Machado, Eduardo ^a   Bianco Junior, Cesare ^a   Riccio, Evelyn Kety Pratt ^a   de Sousa, Maria Auxiliadora ^a   Alecrim, Maria Das Graças Costa ^e   Leite, Nocy ^c   Druilhe, Pierre ^b   Daniel Ribeiro, Claudio Tadeu ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUT PASTEUR   (France)

^c FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^d HOSPITAL DOS SERVIDORES DO ESTADO   (Brazil)

^e FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

Author keywords

Autoantibodies; Autoimmune diseases; Immune protection; Malaria; Systemic Lupus Erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; ANTISERUM; AUTOANTIBODY; AUTOANTIGEN; DNA ANTIBODY;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MICROBIAL GROWTH; NONHUMAN; PARASITE IMMUNITY; PLASMODIUM FALCIPARUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIGENS, PROTOZOAN; AUTOANTIBODIES; CROSS REACTIONS; HUMANS; IMMUNE SERA; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLASMODIUM FALCIPARUM;

EID: 70249085552     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930903039810     Document Type: Article

References (53)

1. Daniel-Ribeiro CT, Zanini G. Autoimmunity and malaria: What are they doing together? Acta Trop 2000;76:205-221.
2. Abu-Shakra M, Shoenfeld Y. Parasitic infection and autoimmunity. Autoimmunity 1991;9:337-344.
3. Yoder BJ, Goodrum KJ. Plasmodium chabaudi chabaudi: B-1 cell expansion correlates with semiresistance in balb/cj mice. Exp Parasitol 2001;98:71-82.
4. Greenwood BM. Autoimmune disease and parasitic infections in nigerians. Lancet 1968;2:380-382.
5. Butcher GA. Sarcoidosis and malaria. Immunol Today 1995; 16:252-253.
6. McNicol MW. Sarcoidosis. In: Cruickshank JK, BeeLer DG, editors. Ethnic factors in health and disease. London: Wright; 1989. p 209-215.
7. Sotgiu S, Angius A, Embry A, Rosati G, Musumeci S. Hygiene hypothesis: Innate immunity, malaria and multiple sclerosis. Med Hypotheses 2008;70:819-825.
8. Zaccone P, Burton OT, Cooke A. Interplay of parasite-driven immune responses and autoimmunity. Trends Parasitol 2008; 24:35-42.
9. Bate CA, Taverne J, Roman E, Moreno C, Playfair JH. Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology 1992;75:129-135.
10. Souza-Passos LF. Apoptosis and SLE: Another piece in the puzzle? Rev Bras Reumatol 1997;37:327-334.
11. Dighiero G. Natural autoantibodies, tolerance, and autoimmunity. Ann N Y Acad Sci 1997;815:182-192.
12. Butcher GA. Malaria and macrophage function in africans: A possible link with autoimmune disease? Med Hypotheses 1996;47:97-100.
13. Butcher G. Autoimmunity and malaria. Trends Parasitol 2008;24:291-292.
14. Perignon JL, Druilhe P. Immune mechanisms underlying the premunition against plasmodium falciparum malaria. Mem Inst Oswaldo Cruz 1994;89 Suppl 2:51-53.
15. Jayawardena AN, Janeway CA, Jr, Kemp JD. Experimental malaria in the cba/ n mouse. J Immunol 1979;123:2532-2539.
16. Jarra W. Protective immunity to malaria and anti-erythrocyte autoimmunity. Ciba Found Symp 1983;94:137-158.
17. Daniel-Ribeiro CT. Is there a role for autoimmunity in immune protection against malaria? Mem Inst Oswaldo Cruz 2000;95:199-207.
18. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI, a disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992;35:630-640.
19. Ferreira AW, Sanches MCA. Malária humana. Padronização e optimização de testes sorológicos para diagnóstico individual e inquéritos soroepidemioló gicos. Rev Inst Med Trop São Paulo 1988;30:137-146.
20. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976;193:673-675.
21. Coen H, Pauwels M, Roels F. The rat liver cell nuclear imprint as a standard for DNA measurements. Anal Cell Pathol 1992; 4:273-285.
22. Aarden LA, de Groot ER, Feltkamp TE. Immunology of DNA. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci 1975;254:505-515.
23. Balthazar-Guedes HC, Ferreira-Da-Cruz MF, Montenegro-James S, Daniel-Ribeiro CT. Malaria diagnosis. Identification of an anti-40-kda polypeptide antibody response associated with active or recent infection and study of the igg/igm ratio of antibodies to blood-stage plasmodium falciparum antigens. Parasitol Res 1995;81:305-309.
24. Banic DM, de Oliveira-Ferreira J, Pratt-Riccio LR, Conseil V, Goncalves D, Fialho RR, Gras-Masse H, Daniel-Ribeiro CT, Camus D. Immune response and lack of immune response to plasmodium falciparum p126 antigen and its amino-terminal repeat in malaria-infected humans. Am J Trop Med Hyg 1998; 58:768-774.
25. James MA, Montenegro-James S, Fajfar-Whetstone C. Immunogenicity and antigenic reactivity of a carrier-free synthetic peptide complex derived from a 70-kda plasmodium falciparum exoantigen. Parasitol Res 1993;79:501-507.
26. Druilhe P, Puebla RM, Miltgen F, Perrin L, Gentilini M. Species- and stage-specific antigens in exoerythrocytic stages of plasmodium falciparum. Am J Trop Med Hyg 1984;33: 336-341.
27. Carvalho LJ, Oliveira SG, Theisen M, Alves FA, Andrade MC, Zanini GM, Brigido MC, Oeuvray C, Povoa MM,Muniz JA, Druilhe P, Daniel-Ribeiro CT. Immunization of saimiri sciureus monkeys with plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels. Scand J Immunol 2004; 59:363-372.
28. Perlmann H, Perlmann P, Berzins K, Wahlin B, Troye-Blomberg M, Hagstedt M, Andersson I, Hogh B, Petersen E, Bjorkman A. Dissection of the human antibody response to the malaria antigen pf155/resa into epitope specific components. Immunol Rev 1989;112:115-132.
29. Dziegiel M, Borre MB, Jepsen S, Hogh B, Petersen E, Vuust J. Recombinant plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1991;44:306-313.
30. Lopez JA, Roggero MA, Duombo O, Gonzalez JM, Tolle R, Koita O, Arevalo-Herrera M, Herrera S, Corradin G. Recognition of synthetic 104-mer and 102-mer peptides corresponding to n- and c-terminal nonrepeat regions of the plasmodium falciparum circumsporozoite protein by sera from human donors. Am J Trop Med Hyg 1996;55:424-429.
31. de Oliveira CI, Wunderlich G, Levitus G, Soares IS, Rodrigues MM, Tsuji M, del Portillo HA. Antigenic properties of the merozoite surface protein 1 gene of plasmodium vivax. Vaccine 1999;17:2959-2968.
32. Lambros C, Vanderberg JP. Synchronization of plasmodium falciparum erythrocytic stages in culture. J Parasitol 1979;65: 418-420.
33. Cunha-Neto E, Iwai LK, Bilate AM, Fonseca SG, Kalil J. Autoimmunity in Chagas disease. In: Shoenfeld Y, Rose N, editors. Infection and autoimmunity. Amsterdam: Elsevier; 2004. p 451-468.
34. Rizzo LV, Cunha-Neto E, Teixeira AR. Autoimmunity in Chagas' disease: Specific inhibition of reactivity of CD4 + t cells against myosin in mice chronically infected with Trypanosoma cruzi. Infect Immun 1989;57:2640-2644.
35. Iwai LK, Juliano MA, Juliano L, Kalil J, Cunha-Neto E. T-cell molecular mimicry in chagas disease: Identification and partial structural analysis of multiple cross-reactive epitopes between trypanosoma cruzi b13 and cardiac myosin heavy chain. J Autoimmun 2005;24:111-117.
36. Tadokoro CE, Vallochi AL, Rios LS, Martins GA, Schlesinger D, Mosca T, Kuchroo VK, Rizzo LV, Abrahamsohn IA. Experimental autoimmune encephalomyelitis can be prevented and cured by infection with Trypanosoma cruzi. J Autoimmun 2004;23:103-115.
37. Greenwood BM, Herrick EM, Voller A. Suppression of autoimmune disease in nzb and (nzb × nzw) f1 hybrid mice by infection with malaria. Nature 1970;226:266-267.
38. Hentati B, Sato MN, Payelle-Brogard B, Avrameas S, Ternynck T. Beneficial effect of polyclonal immunoglobulins from malaria-infected balb/c mice on the lupus-like syndrome of (nzb × nzw)f1 mice. Eur J Immunol 1994;24:8-15.
39. Berlin T, Zandman-Goddart G, Blank M, Matthias T, Pfeiffer S, Weiss I, Toubi E, Singh S, Asherson R, Frazer A, Gilburd B, Sapir T, Levy Y, Lukac J, Rozman B, Kveder T, Shoenfeld Y. Autoantibodies in nonautoimmune individuals during infections. Ann N Y Acad Sci 2007;1108:584-593.
40. Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Thromb Haemost 2002;87:599-605.
41. Dugué C, Perraut C, Youinou P, Renaudineau Y. Effects of anti-endothelial cell antibodies in leprosy and malaria. Infect Immun 2004;72:301-309.
42. Milner ECB, Anolik J, Cappione A, Sanz I. Human innate B cells: A link between host defense and autoimmunity? Springer Semin Immun 2005;26:433-452.
43. Baker VS, Imade GE, Molta NB, Tawde P, Pam SD, Obadofin MO, Sagay SA, Egah DZ, Iya D, Afolabi BB, Baker M, Ford K, Ford R, Roux KH, Keller TC, III. Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in plasmodium falciparum infected children under six years of age. Malar J 2008;7:41.
44. Consigny PH, Cauquelin B, Agnamey P, Comby E, Brasseur P, Ballet JJ, Roussilhon C. High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals. Clin Exp Immunol 2002;127:158-164.
45. Daniel-Ribeiro C, Kalil J, Monjour L, Alfred C, Ploton I, Gentilini M. Cross reactions between plasmodium falciparum and mammalian tissue antigens detected by monoclonal antibodies. Ann Trop Med Parasitol 1984;78:75-76.
46. Oldstone MB. Molecular mimicry, microbial infection, and autoimmune disease: Evolution of the concept. Curr Top Microbiol Immunol 2005;296:1-17.
47. Karlsen AE, Dyrberg T. Molecular mimicry between non-self, modified self and self in autoimmunity. Semin Immunol 1998; 10:25-34.
48. Du H, Chen M, Zhang Y, Zhao MH, Wang HY. Crossreaction of anti-DNA autoantibodies with membrane proteins of human glomerular mesangial cells in sera from patients with lupus nephritis. Clin Exp Immunol 2006;145:21-27.
49. Eilat D, Zlotnick AY, Fischel R. Evaluation of the crossreaction between anti-DNA and anti-cardiolipin antibodies in SLE and experimental animals. Clin Exp Immunol 1986;65: 269-278.
50. Maguire PA, Prudhomme J, Sherman IW. Alterations in erythrocyte membrane phospholipid organization due to the intracellular growth of the human malaria parasite, plasmodium falciparum. Parasitology 1991;102:179-186.
51. Singh S, Chatterjee S, Sohoni R, Badakere S, Sharma S. Sera from lupus patients inhibit growth of P falciparum in culture. Autoimmunity 2001;33:253-263.
52. Carvalho LJ, Daniel-Ribeiro CT, Goto H. Malaria vaccine: Candidate antigens, mechanisms, constraints and prospects. Scand J Immunol 2002;56:327-343.
53. Langhorne J, Ndungu FM, Sponaas AM,Marsh K. Immunity to malaria: More questions than answers. Nat Immunol 2008; 9:725-732.